One possible risk factor for tuberculosis is diabetes, a condition characterized by high blood sugar levels and long-term complications involving the circulation, eyes and kidneys, and the body’s ability to fight infection.
Active tuberculosis can be cured by taking a combination of several antibiotics every day for at least six months, and current control efforts concentrate on prompt detection and carefully monitored treatment of people with active tuberculosis to prevent further transmission of the bacteria.
Despite this control strategy, tuberculosis remains a major health problem in many countries. To reduce the annual number of new tuberculosis cases (incidence) and the number of people with tuberculosis (prevalence) in such countries, it may be necessary to identify and target factors that increase an individual’s risk of developing active tuberculosis.
180 million people currently have diabetes, but this number is expected to double by 2030.
Low-to middle-income countries (for example, India and China) have the highest burden of tuberculosis and are experiencing the fastest increase in diabetes prevalence.
If diabetes does increase the risk of developing active tuberculosis, this overlap between the diabetes and tuberculosis epidemics could adversely affect global tuberculosis control efforts.
In a recent study researchers undertook a systematic review (a search using specific criteria to identify relevant research studies, which are then appraised) and a random effects meta-analysis (a type of statistical analysis that pools the results of several studies) to learn more about the association between diabetes and tuberculosis.
From their search of electronic databases, the researchers found 13 observational studies (non-experimental investigations that record individual characteristics and health outcomes without trying to influence them in any way) that had examined whether type 2 diabetes increases the risk of active tuberculosis.
Diabetes was positively associated with tuberculosis in all but one study, but the estimates of how much diabetes increases the risk of developing active tuberculosis were highly variable, ranging from no effect to an increased risk of nearly 8-fold in one study.
The variability may represent true differences between the study populations, as higher increases in risk due to diabetes was found in studies conducted outside of North America, including Central America, Europe, and Asia; or it may reflect differences in how well each study was done.
The extent to which these observations varied meant that the researchers could not include all of the studies in their meta-analysis.
However, the three prospective cohort studies (studies that follow a group of individuals with potential risk factors for a disease over time to see if they develop that disease) that they had identified in their systematic review had more consistent effects estimates, and were included in the meta-analysis.
This meta-analysis showed that, compared to people without diabetes, people with diabetes had a 3-fold increased risk of developing active tuberculosis.
The above findings support the idea that diabetes increases the risk of tuberculosis, a biologically plausible idea because, in experimental and clinical studies, diabetes was found to impair the immune responses needed to control bacterial infections.
The 3-fold increased risk of tuberculosis associated with diabetes that the meta-analysis reveals suggests that diabetes may already be responsible for more than 10% of tuberculosis cases in countries such as India and China, a figure that will likely increase as diabetes becomes more common.
However, the estimate of this impact is based on three cohort studies from Asia; other studies suggest that the extent of the impact due to diabetes may vary by region and ethnicity.
In populations where diabetes affects the risk of tuberculosis to a similar or greater extent, global tuberculosis control might benefit from active case finding and treatment of dormant tuberculosis in people with diabetes and from increased efforts to diagnose and treat diabetes.
Every year, 8.8 million people develop active tuberculosis and 1.6 million people die from this highly contagious infection that usually affects the lungs.
Tuberculosis is caused by Mycobacterium tuberculosis, bacteria that are spread through the air when people with active tuberculosis cough or sneeze.
Most infected people never become illâ€”a third of the world’s population is actually infected with M. tuberculosisâ€”because the human immune system usually contains the infection.
However, the bacteria remain dormant within the body and can cause disease many years later if host immunity declines because of increasing age or because of other medical conditions such as HIV infection.
Jeon CY, Murray MB (2008) Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies. PLoS Med 5(7): e152. doi:10.1371/journal.pmed.0050152. Copyright: Â© 2008 Jeon and Murray. This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Heart Disease May Be Reversible in Adults with Diabetes
Diabetes and Cinnamon
Type 2 Diabetes Among Hispanics and Resistance Training
Leptin and Insulin: The Effects of Glucose and Fructose
Gymnema – An Effective Treatment for Type 2 Diabetes
Type 2 Diabetes Is Carbohydrate Intolerance
More Articles of Interest:
- Gymnema – An Effective Treatment for Type 2 Diabetes
- Intensive Treatment of Type 2 Diabetes May Be Fatal
- Type 2 Diabetes Is Carbohydrate Intolerance
- Diabetes: Kidney Damage Reversed
- Heart Disease May Be Reversible in Adults with Diabetes
- The Odds of Dying of Lung Cancer for Non Smokers
- Type 2 Diabetes Among Hispanics and Resistance Training
- High Blood Pressure and Preeclampsia During Pregnancy – Future Risks